Your browser doesn't support javascript.
Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection.
Bosserman, Rachel E; Farnsworth, Christopher W; O'Neil, Caroline A; Cass, Candice; Park, Daniel; Ballman, Claire; Wallace, Meghan A; Struttmann, Emily; Stewart, Henry; Arter, Olivia; Peacock, Kate; Fraser, Victoria J; Budge, Philip J; Olsen, Margaret A; Burnham, Carey-Ann D; Babcock, Hilary M; Kwon, Jennie H.
  • Bosserman RE; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Farnsworth CW; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri.
  • O'Neil CA; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Cass C; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Park D; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Ballman C; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri.
  • Wallace MA; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri.
  • Struttmann E; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Stewart H; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Arter O; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Peacock K; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Fraser VJ; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Budge PJ; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Olsen MA; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Burnham CD; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri.
  • Babcock HM; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Kwon JH; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Antimicrob Steward Healthc Epidemiol ; 2(1): e93, 2022.
Article in English | MEDLINE | ID: covidwho-20233422
ABSTRACT
In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Antimicrob Steward Healthc Epidemiol Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Antimicrob Steward Healthc Epidemiol Year: 2022 Document Type: Article